company background image
539561 logo

Remedium Lifecare BSE:539561 Stock Report

Last Price

₹109.80

Market Cap

₹11.1b

7D

-1.1%

1Y

126.3%

Updated

23 Apr, 2024

Data

Company Financials

Remedium Lifecare Limited

BSE:539561 Stock Report

Market Cap: ₹11.1b

539561 Stock Overview

Remedium Lifecare Limited, a pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally.

539561 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance6/6
Financial Health4/6
Dividends0/6

Remedium Lifecare Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Remedium Lifecare
Historical stock prices
Current Share Price₹109.80
52 Week High₹179.66
52 Week Low₹47.18
Beta1.05
1 Month Change2.14%
3 Month Change10.85%
1 Year Change126.25%
3 Year Change6,285.05%
5 Year Change20,396.01%
Change since IPO24,300.05%

Recent News & Updates

Recent updates

Shareholder Returns

539561IN PharmaceuticalsIN Market
7D-1.1%-1.4%-1.6%
1Y126.3%53.7%45.0%

Return vs Industry: 539561 exceeded the Indian Pharmaceuticals industry which returned 53.7% over the past year.

Return vs Market: 539561 exceeded the Indian Market which returned 45% over the past year.

Price Volatility

Is 539561's price volatile compared to industry and market?
539561 volatility
539561 Average Weekly Movement11.7%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.9%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 539561's share price has been volatile over the past 3 months.

Volatility Over Time: 539561's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
19887Adarsh Munjalwww.remlife.com

Remedium Lifecare Limited, a pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. It offers API intermediates and various other raw materials for the use in API manufacturing, including amino isophthalic acids, tellurium(IV) oxides, grignard reagents, iodine, selenium metal powders, and trimethyl sulfoxonium iodide. The company was formerly known as Roxy Exports Limited and changed its name to Remedium Lifecare Limited in November 2020.

Remedium Lifecare Limited Fundamentals Summary

How do Remedium Lifecare's earnings and revenue compare to its market cap?
539561 fundamental statistics
Market cap₹11.06b
Earnings (TTM)₹528.08m
Revenue (TTM)₹27.25b

21.0x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
539561 income statement (TTM)
Revenue₹27.25b
Cost of Revenue₹26.33b
Gross Profit₹920.40m
Other Expenses₹392.32m
Earnings₹528.08m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)5.24
Gross Margin3.38%
Net Profit Margin1.94%
Debt/Equity Ratio5.3%

How did 539561 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.